Description

S-[2-[3-[[(2R)-4-[[[(2R,3R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (8Z,11Z,14Z,17Z)-tricosa-8,11,14,17-tetraenethioate is a sophisticated, high-purity biochemical intermediate of significant interest in advanced pharmaceutical research and development. This compound is a conjugate molecule that combines structural motifs of a modified nucleotide with a polyunsaturated fatty acid thioester, making it a critical building block for probing cellular signaling pathways and metabolic processes. It is primarily utilized by research institutions, pharmaceutical R&D departments, and biotechnology companies engaged in the synthesis of novel therapeutic agents and molecular probes.

Application

• Pharmaceutical Research & Development: Serves as a key synthetic intermediate or precursor in the development of novel nucleotide-based therapeutics and prodrugs.
• Biochemical Probe Synthesis: Used to create specialized probes for studying enzyme kinetics, lipid metabolism, and intracellular signaling cascades involving fatty acid modifications.
• Antiviral/Anticancer Agent Development: Investigated as a building block for potential antiviral or anticancer compounds due to its nucleotide analog structure.
• Metabolic Pathway Studies: Employed in research to trace and understand complex biochemical pathways related to nucleotide and lipid biology.
• High-Value Fine Chemical Synthesis: Acts as a critical intermediate in multi-step organic syntheses for producing complex, target-specific molecules.
• Reference Standard: Used as a high-purity analytical standard for quality control and method validation in pharmaceutical analysis.

Basic Information

Item	Details
Product Name	S-[2-[3-[[(2R)-4-[[[(2R,3R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (8Z,11Z,14Z,17Z)-tricosa-8,11,14,17-tetraenethioate
CAS No.	28879-98-3
Molecular Formula	C38H64N7O16P3S
Molecular Weight	999.93 g/mol
Synonyms	Adenosine triphosphate derivative fatty acid conjugate; Coenzyme A analog; ATP-fatty acid thioester; Modified nucleotide-lipid conjugate; S-Acylated CoA analog; (8Z,11Z,14Z,17Z)-Tricosa-8,11,14,17-tetraenethioic acid S-[2-[3-[[(2R)-4-[[[(2R,3R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] ester; Long-chain fatty acyl-ATP derivative
EINECS	Contact for details

Quality Control

This high-value biochemical is produced under strict quality control protocols to ensure batch-to-batch consistency and purity suitable for research applications. Each lot is characterized using advanced analytical techniques including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment to support your regulatory and research documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below. This compound is hygroscopic (moisture-sensitive) and should be handled under an inert atmosphere (argon or nitrogen) when opening to prevent degradation. Allow the sealed vial to equilibrate to room temperature before opening to minimize moisture ingress.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 2.0%
Heavy Metals	≤ 20 ppm
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.